Enterprise Financial Services Corp (EFSC)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-64
| Closed | -$7K | – | 1323 |
|
|
2019
Q4 | $7K | Hold |
64
| – | – | ﹤0.01% | 799 |
|
|
2019
Q3 | $6K | Sell |
64
-6,000
| -99% | -$563K | ﹤0.01% | 822 |
|
|
2019
Q2 | $511K | Hold |
6,064
| – | – | 0.11% | 121 |
|
|
2019
Q1 | $535K | Buy |
6,064
+6,000
| +9,375% | +$529K | 0.12% | 120 |
|
|
2018
Q4 | $5K | Hold |
64
| – | – | ﹤0.01% | 660 |
|
|
2018
Q3 | $8K | Buy |
+64
| New | +$8K | ﹤0.01% | 644 |
|
|
2017
Q2 | – | Sell |
-23
| Closed | -$1K | – | 1006 |
|
|
2017
Q1 | $1K | Sell |
23
-42
| -65% | -$1.83K | ﹤0.01% | 1022 |
|
|
2016
Q4 | $3K | Sell |
65
-150
| -70% | -$6.92K | ﹤0.01% | 852 |
|
|
2016
Q3 | $11K | Hold |
215
| – | – | 0.01% | 545 |
|
|
2016
Q2 | $10K | Buy |
+215
| New | +$10K | 0.01% | 549 |
|
|
2016
Q1 | – | Sell |
-257
| Closed | -$15K | – | 1107 |
|
|
2015
Q4 | $15K | Hold |
257
| – | – | 0.01% | 472 |
|
|
2015
Q3 | $10K | Buy |
+257
| New | +$10K | 0.01% | 541 |
|